<DOC>
	<DOC>NCT00219440</DOC>
	<brief_summary>We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.</brief_summary>
	<brief_title>A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS</brief_title>
	<detailed_description>A total of 60 male and female type 2 diabetic subjects will be recruited and randomized into 1 of 3 treatment groups for the 4 months long trial 1. ACTOS plus a standard diet 2. ACTOS plus a portion-controlled diet 3. Metformin plus a standard diet. The end-point of the trial is the change in body fat content from baseline to the end of the trial</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Men and women age 35 to 75 who have type 2 diabetes mellitus Individuals with coexisting other diseases</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>